367 related articles for article (PubMed ID: 28409892)
21. Aggressive Imaging Features in a Malignant Pheochromocytoma With a Novel Mutation of the SDHB Gene.
Park SA; Lee DH; Kim HS
Clin Nucl Med; 2017 Sep; 42(9):687-689. PubMed ID: 28650885
[TBL] [Abstract][Full Text] [Related]
22. Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.
Janssen I; Blanchet EM; Adams K; Chen CC; Millo CM; Herscovitch P; Taieb D; Kebebew E; Lehnert H; Fojo AT; Pacak K
Clin Cancer Res; 2015 Sep; 21(17):3888-95. PubMed ID: 25873086
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.
Kamai T; Murakami S; Arai K; Nishihara D; Uematsu T; Ishida K; Kijima T
BMC Cancer; 2022 Mar; 22(1):289. PubMed ID: 35300626
[TBL] [Abstract][Full Text] [Related]
24. Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.
Singh D; Shukla J; Walia R; Vatsa R; Paul N; Chhabra A; Nahar U; Singh H; Kumar R; Bhansali A; Rai Mittal B
Nucl Med Commun; 2020 Oct; 41(10):1047-1059. PubMed ID: 32732602
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of [
Takenaka J; Watanabe S; Abe T; Hirata K; Uchiyama Y; Kimura R; Shinohara N; Kudo K
Ann Nucl Med; 2023 Jan; 37(1):10-17. PubMed ID: 36301465
[TBL] [Abstract][Full Text] [Related]
26. Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.
Puar T; van Berkel A; Gotthardt M; Havekes B; Hermus AR; Lenders JW; van Marken Lichtenbelt WD; Xu Y; Brans B; Timmers HJ
J Clin Endocrinol Metab; 2016 Jan; 101(1):224-32. PubMed ID: 26574955
[TBL] [Abstract][Full Text] [Related]
27. Paragangliomas and Pheochromocytomas: Positron Emission Tomography/Computed Tomography Diagnosis and Therapy.
Marcus C; Subramaniam RM
PET Clin; 2023 Apr; 18(2):233-242. PubMed ID: 36585340
[TBL] [Abstract][Full Text] [Related]
28. 18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.
Blanchet EM; Taieb D; Millo C; Martucci V; Chen CC; Merino M; Herscovitch P; Pacak K
J Nucl Med; 2015 Dec; 56(12):1849-54. PubMed ID: 26359261
[TBL] [Abstract][Full Text] [Related]
29.
Krokhmal AA; Kwatra N; Drubach L; Weldon CB; Janeway KA; DuBois SG; Kamihara J; Voss SD
Pediatr Blood Cancer; 2022 Aug; 69(8):e29740. PubMed ID: 35484995
[TBL] [Abstract][Full Text] [Related]
30.
Kan Y; Zhang S; Wang W; Liu J; Yang J; Wang Z
Acta Radiol; 2018 Dec; 59(12):1466-1474. PubMed ID: 29566550
[TBL] [Abstract][Full Text] [Related]
31. Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma.
Nakano S; Tsushima Y; Higuchi T; Taketomi-Takahashi A; Amanuma M
Jpn J Radiol; 2012 May; 30(4):310-6. PubMed ID: 22271156
[TBL] [Abstract][Full Text] [Related]
32. Imagenomics. Findings in PET with 68Ga-DOTA-TOC associated with the detection of the mutation of the succinate dehydrogenase B (SDHB) gene in the screening of hereditary pheochromocytoma/paraganglioma.
Ortiz Banguera S; Busquets Carrera O; Ysamat M; Gonzalez JM; Riera Gil E; Garcia JR
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(4):268-270. PubMed ID: 35668017
[No Abstract] [Full Text] [Related]
33. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS
Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829
[TBL] [Abstract][Full Text] [Related]
34. [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.
Mann GN; Link JM; Pham P; Pickett CA; Byrd DR; Kinahan PE; Krohn KA; Mankoff DA
Ann Surg Oncol; 2006 Feb; 13(2):187-97. PubMed ID: 16418883
[TBL] [Abstract][Full Text] [Related]
35. Multimodality Radionuclide Imaging in a Patient With Hereditary Paraganglioma-Pheochromocytoma Syndrome.
Yim SY; Moncayo VM; Pasquel FJ; Halkar RK
Clin Nucl Med; 2017 Dec; 42(12):964-965. PubMed ID: 28902732
[TBL] [Abstract][Full Text] [Related]
36. Imaging of pheochromocytoma and paraganglioma.
Brink I; Hoegerle S; Klisch J; Bley TA
Fam Cancer; 2005; 4(1):61-8. PubMed ID: 15883712
[TBL] [Abstract][Full Text] [Related]
37. Implications of SDHB genetic testing in patients with sporadic pheochromocytoma.
Maignan A; Guerin C; Julliard V; Paladino NC; Kim E; Roche P; Castinetti F; Essamet W; Mancini J; Imperiale A; Clifton-Bligh R; Romanet P; Barlier A; Pacak K; Sebag F; Taïeb D
Langenbecks Arch Surg; 2017 Aug; 402(5):787-798. PubMed ID: 28229225
[TBL] [Abstract][Full Text] [Related]
38. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
Rischke HC; Benz MR; Wild D; Mix M; Dumont RA; Campbell D; Seufert J; Wiech T; Rössler J; Weber WA; Neumann HP
J Nucl Med; 2012 Sep; 53(9):1352-8. PubMed ID: 22836345
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?
Taïeb D; Sebag F; Barlier A; Tessonnier L; Palazzo FF; Morange I; Niccoli-Sire P; Fakhry N; De Micco C; Cammilleri S; Enjalbert A; Henry JF; Mundler O
J Nucl Med; 2009 May; 50(5):711-7. PubMed ID: 19372492
[TBL] [Abstract][Full Text] [Related]
40. Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.
Jawed I; Velarde M; Därr R; Wolf KI; Adams K; Venkatesan AM; Balasubramaniam S; Poruchynsky MS; Reynolds JC; Pacak K; Fojo T
Cell Mol Neurobiol; 2018 Jul; 38(5):1099-1106. PubMed ID: 29623478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
